“Clinical Significance of Anti-U1 Ribonucleoprotein Antibody in Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis Patients: A Retrospective Observational Study”. 2021. Archives of Clinical and Biomedical Research 5 (1): 76-84. https://fortunejournals.org/ojs/index.php/acbr/article/view/14819.